ORXE Stock UPDATES Ore Pharmaceuticals (ORXE) 0.4000 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 3, 2014 at 11:53 AM

Ore Pharmaceuticals (ORXE) 0.4000 $ORXE

Novavax Announces Management Promotions
Thomson Reuters ONE - Thu Jun 19, 3:26PM CDT
GAITHERSBURG, Md., June 19, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today a number of promotions within its management team.

NYSE Questions Houston American Energy Corp.'s Unusual Market Activity
ACCESSWIRE - Wed Mar 12, 8:25AM CDT
Houston American Energy Corp. (NYSE: HUSA) stock volume soared Mar. 11, with 2,384,313 shares changing hands, nearly five times its three-month average volume of 502,308 shares.

Canfor Corporation and Canfor Pulp Products Inc. Announce Fourth Quarter Results Conference Call
Marketwire - Wed Jan 15, 5:19PM CST
Canfor Corporation (TSX: CFP) and Canfor Pulp Products Inc. (TSX: CFX) will hold a joint conference call on Thursday, February 6, 2014 at 8:00 AM PST to discuss their respective fourth quarter 2013 financial and operating results. To participate in the call, please dial one of the following numbers:

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2013 Reviews Key Players Involved In the Therapeutic Development for Functional Dyspepsia
M2 - Mon Sep 02, 9:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lbqxmb/functional_non) has announced the addition of the "Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Functional (Non Ulcer) Dyspepsia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Functional (Non Ulcer) Dyspepsia. Functional (Non Ulcer) Dyspepsia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Functional (Non Ulcer) Dyspepsia. - A review of the Functional (Non Ulcer) Dyspepsia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Functional (Non Ulcer) Dyspepsia pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned: - Eisai Co., Ltd. - Zeria Pharmaceutical Co Ltd - Ore Pharmaceuticals Inc - AGI Therapeutics plc - Ironwood Pharmaceuticals, Inc. - RaQualia Pharma Inc. For more information visit http://www.researchandmarkets.com/research/lb...tional_non About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Gastric Ulcers - Pipeline Review, H1 2013
M2 - Thu Jul 18, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t63njg/gastric_ulcers) has announced the addition of the "Gastric Ulcers - Pipeline Review, H1 2013" report to their offering. 'Gastric Ulcers - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gastric Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastric Ulcers. Scope - A snapshot of the global therapeutic scenario for Gastric Ulcers. - A review of the Gastric Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Gastric Ulcers pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Involved in Gastric Ulcers Therapeutics Development - Takeda Pharmaceutical Company Limited - Daewoong Pharmaceutical Co., Ltd. - Eisai Co., Ltd. - Ore Pharmaceuticals Inc - Sihuan Pharmaceutical Holdings Group Ltd. - HeliCure AB Drug Profiles - vonoprazan - DWJ-206 - Helicobacter Pylori Vaccine - ebselen - PMKS-005 - Acid Pump Antagonists - Anaprazole For more information visit http://www.researchandmarkets.com/research/t6...ric_ulcers

Ulcers - Pipeline Review, H1 2013
M2 - Fri Jul 12, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4fgbql/ulcers_pipeline) has announced the addition of the "Ulcers - Pipeline Review, H1 2013" report to their offering. The research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ulcers. The data is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by a team of experts. Scope - A snapshot of the global therapeutic scenario for Ulcers. - A review of the Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-spec

Ore Pharmaceuticals Inc - Product Pipeline Review - 2012
M2 - Mon Feb 18, 4:08AM CST
Summary

Inflammatory Bowel Disease - Pipeline Review, H2 2012 Out Now
M2 - Fri Jan 04, 10:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/pf73r6/inflammatory) has announced the addition of Global Markets Direct's new report "Inflammatory Bowel Disease - Pipeline Review, H2 2012" to their offering. Global Markets Direct's, 'Inflammatory Bowel Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Inflammatory Bowel Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Inflammatory Bowel Disease. Inflammatory Bowel Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Medicare Payment Proposal Faces Doctor Backlash in D.C.

Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...

Superga and Pasqua's Unlikely Fashion-Vineyard Fusion

Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...

EPR Fireworks, Schedule2.IT Enhance EMS Integration

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Crucial Insights for South GA Home Insurance Choices

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

JennAir and Cosentino Introduce Seamless Kitchen Aesthetics

It's not every day that the kitchen landscape gets a bold makeover, but JennAir and Cosentino seem to think it's time. Introducing their latest splash, the JennAir x Dekton panel collection is here to redefine what luxury kitchens can look like—an embodiment of seamless beauty that’s more sculpture than cooking space. Elevating Kitchen Design So, what's the buzz about...

Vortex Expands UK Reach with Torrent Acquisition Boost

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

University of Phoenix Grads Shine in Job Readiness

University of Phoenix Graduates Proving Their Worth Dive straight into the world of University of Phoenix grads, and you're looking at some folks who seem to have the workplace game figured out. A fresh Harris Poll, done on behalf of the University itself, paints a rosy picture of these graduates from the eyes of those who actually supervise them. Turns out, managers are...

Reel Wheels: Hollywood's Iconic Car Collection Unveiled

Rolling Out the Legends: A Peek Inside Reel Wheels Picture something that screams Hollywood. Now, give it wheels, maybe some wings too. That's what Reel Wheels Entertainment has laid out—a mind-boggling assortment of film and TV vehicles. Released on September 30, 2026, this collection is a treasure trove of Hollywood's on-screen memorabilia, and they're not just...

FSS Unveils AI Tool to Simplify Bankruptcy Cases

AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....